PVLA Palvella Therapeutics misses earnings estimates by 26 as stock drops nearly 13 amid pipeline concerns SBFM Sunshine Biopharma posts wider than expected Q4 2025 loss as shares close unchanged for the trading day The strategic moves FS Credit FSCO is making now 212 20260505 JCAP Jefferson Capital posts narrow Q4 2025 EPS beat shares rise 154 percent on mild positive investor sentiment